MedTrace Logo

Effectiveness of Interscalene Brachial Plexus Block and Intra-articular Injection of Ropivacaine for Post-operative Analgesia in Arthroscopic Shoulder Stabilization Surgery

NCT01589354 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-05-02

No results posted yet for this study

Summary

This study evaluates two anaesthetic techniques namely interscalene brachial plexus block and intra-articular local anaesthetic injection. Both techniques are currently used for providing postoperative pain relief following arthroscopic shoulder stabilisation operation. It will be a randomised controlled trial involving 30 patients in two groups.

Conditions

  • Postoperative Analgesia

Interventions

PROCEDURE

Interscalene brachial plexus block

An interscalene block will be performed pre-operatively using ultrasound guidance and the peripheral nerve stimulator (with the patient awake) using 20 ml of 0.375% Ropivacaine.

PROCEDURE

Intra-articular Ropivacaine injection

The procedure will be done by the surgeon at the end of the operation, with an intra-articular injection of 20 ml 0.75% Ropivacaine through the arthroscopic cannula after closure of the anterior wound

DEVICE

Ultrasound guided technique

The block will be performed under U/S guidance

DRUG

Ropivacaine

20ml of 0.375% Ropivacaine

DRUG

Ropivacaine

20ml of 0.75% Ropivacaine injected by the surgeon at the end of the procedure

Sponsors & Collaborators

  • NHS Grampian

    lead OTHER_GOV

Principal Investigators

  • Amr M Mahdy, MD · NHS Grampian

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-05-31
Completion
2014-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01589354 on ClinicalTrials.gov